- Company Overview for COLONIS PHARMA LIMITED (05486832)
- Filing history for COLONIS PHARMA LIMITED (05486832)
- People for COLONIS PHARMA LIMITED (05486832)
- Charges for COLONIS PHARMA LIMITED (05486832)
- More for COLONIS PHARMA LIMITED (05486832)
Date (document was filed at Companies House) | Type | Description (of the document filed at Companies House) | View / Download (PDF file, link opens in new window) |
---|---|---|---|
27 Jun 2024 | CS01 | Confirmation statement made on 18 June 2024 with no updates | |
24 Jun 2024 | AP01 | Appointment of Mr Nihad Hasagic as a director on 19 June 2024 | |
16 May 2024 | AP03 | Appointment of Mr Richard Edward Adair as a secretary on 30 April 2024 | |
10 Apr 2024 | AA | Audit exemption subsidiary accounts made up to 30 June 2023 | |
10 Apr 2024 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 30/06/23 | |
10 Apr 2024 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 30/06/23 | |
10 Apr 2024 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 30/06/23 | |
20 Jun 2023 | CS01 | Confirmation statement made on 18 June 2023 with no updates | |
05 May 2023 | AA | Audit exemption subsidiary accounts made up to 30 June 2022 | |
05 May 2023 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 30/06/22 | |
05 May 2023 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 30/06/22 | |
05 May 2023 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 30/06/22 | |
06 Mar 2023 | AP01 | Appointment of Mr Richard John Paling as a director on 6 March 2023 | |
27 Feb 2023 | CH01 | Director's details changed for Ipatia Efraimidou on 24 June 2021 | |
01 Feb 2023 | TM02 | Termination of appointment of Amanda Miller as a secretary on 16 January 2023 | |
09 Sep 2022 | MR01 | Registration of charge 054868320005, created on 7 September 2022 | |
08 Jul 2022 | CS01 | Confirmation statement made on 18 June 2022 with updates | |
01 Apr 2022 | AA | Audit exemption subsidiary accounts made up to 30 June 2021 | |
01 Apr 2022 | PARENT_ACC | Consolidated accounts of parent company for subsidiary company period ending 30/06/21 | |
01 Apr 2022 | AGREEMENT2 | Notice of agreement to exemption from audit of accounts for period ending 30/06/21 | |
01 Apr 2022 | GUARANTEE2 | Audit exemption statement of guarantee by parent company for period ending 30/06/21 | |
18 Mar 2022 | TM01 | Termination of appointment of Julia Carolina Von Samson Himmelstjerna as a director on 14 February 2022 | |
03 Dec 2021 | PSC07 | Cessation of Quantum Pharmaceutical Limited as a person with significant control on 25 June 2021 | |
03 Dec 2021 | PSC02 | Notification of Clinigen Healthcare Limited as a person with significant control on 25 June 2021 | |
12 Aug 2021 | AD01 | Registered office address changed from 25 Bedford Square Bloomsbury London WC1B 3HW United Kingdom to 25 Bedford Square Bloomsbury London WC1B 3HH on 12 August 2021 |